MHRA Class 2 Medicines Recall: MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution (Eastone Limited)

MHRA Class 2 Medicines Recall: MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution (Eastone Limited)

February 17, 2021

Class 2 Medicines recall: MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution (Eastone Limited)

Drug alert number: EL (21) A/04

Date issued: 16th February 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:

MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution (Eastone Limited) MS 3297

Eaststone Limited has informed MHRA of an issue related to underfilled or empty bottles for MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution. The below batch is being recalled.

Batch Number Expiry Date Pack Size First Distributed
ES84553 15 April 2021 5ml 26 April 2019

Advice for healthcare professionals

Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Full drug alert can be viewed here.

Company contacts for further information

For more information or medical information queries contact Eaststone at specials@eaststone.co.uk or alternatively call 0800 678 3102.



Posted in: , ,


More Latest News >

Briefing MPs on COVID-19 costs

PSNC is continuing its work to brief Parliamentarians on the financial pressures facing community pharmacies. Ahead of the Budget, PSNC...

No Smoking Day 2021

No Smoking Day is a national campaign that encourages the nation’s smokers to make a quit attempt on the second...

PEPS payments information

Contractors signed up to the Pharmacy Earlier Payments Scheme (PEPS) will have received their payments on 1 March directly from...